306 related articles for article (PubMed ID: 27187792)
1. Nanoemulsion: for improved oral delivery of repaglinide.
Akhtar J; Siddiqui HH; Fareed S; Badruddeen ; Khalid M; Aqil M
Drug Deliv; 2016 Jul; 23(6):2026-34. PubMed ID: 27187792
[TBL] [Abstract][Full Text] [Related]
2. Improved oral bioavailability of repaglinide, a typical BCS Class II drug, with a chitosan-coated nanoemulsion.
Karami Z; Saghatchi Zanjani MR; Nasihatsheno N; Hamidi M
J Biomed Mater Res B Appl Biomater; 2020 Apr; 108(3):717-728. PubMed ID: 31187938
[TBL] [Abstract][Full Text] [Related]
3. Nanomulsion as a carrier for efficient delivery of metformin.
Akhtar J; Siddiqui HH; Badruddeen ; Fareed S; Aqil M
Curr Drug Deliv; 2014; 11(2):243-52. PubMed ID: 24410150
[TBL] [Abstract][Full Text] [Related]
4. Development and bioavailability assessment of ramipril nanoemulsion formulation.
Shafiq S; Shakeel F; Talegaonkar S; Ahmad FJ; Khar RK; Ali M
Eur J Pharm Biopharm; 2007 May; 66(2):227-43. PubMed ID: 17127045
[TBL] [Abstract][Full Text] [Related]
5. Repaglinide-loaded long-circulating biodegradable nanoparticles: rational approach for the management of type 2 diabetes mellitus.
Jain S; Saraf S
J Diabetes; 2009 Mar; 1(1):29-35. PubMed ID: 20923517
[TBL] [Abstract][Full Text] [Related]
6. Oil based nanocarrier for improved oral delivery of silymarin: In vitro and in vivo studies.
Parveen R; Baboota S; Ali J; Ahuja A; Vasudev SS; Ahmad S
Int J Pharm; 2011 Jul; 413(1-2):245-53. PubMed ID: 21549187
[TBL] [Abstract][Full Text] [Related]
7. Studies on binary lipid matrix based solid lipid nanoparticles of repaglinide: in vitro and in vivo evaluation.
Rawat MK; Jain A; Singh S
J Pharm Sci; 2011 Jun; 100(6):2366-78. PubMed ID: 21491449
[TBL] [Abstract][Full Text] [Related]
8. Design and Development of Repaglinide Microemulsion Gel for Transdermal Delivery.
Shinde UA; Modani SH; Singh KH
AAPS PharmSciTech; 2018 Jan; 19(1):315-325. PubMed ID: 28717973
[TBL] [Abstract][Full Text] [Related]
9. Study of surfactant combinations and development of a novel nanoemulsion for minimising variations in bioavailability of ezetimibe.
Bali V; Ali M; Ali J
Colloids Surf B Biointerfaces; 2010 Apr; 76(2):410-20. PubMed ID: 20042320
[TBL] [Abstract][Full Text] [Related]
10. Anticancer efficacy, tissue distribution and blood pharmacokinetics of surface modified nanocarrier containing melphalan.
Rajpoot P; Bali V; Pathak K
Int J Pharm; 2012 Apr; 426(1-2):219-230. PubMed ID: 22301424
[TBL] [Abstract][Full Text] [Related]
11. In vivo and cytotoxicity evaluation of repaglinide-loaded binary solid lipid nanoparticles after oral administration to rats.
Rawat MK; Jain A; Singh S
J Pharm Sci; 2011 Jun; 100(6):2406-17. PubMed ID: 21491451
[TBL] [Abstract][Full Text] [Related]
12. Preparation, characterization and in vivo evaluation of formulation of repaglinide with hydroxypropyl-β-cyclodextrin.
Liu M; Cao W; Sun Y; He Z
Int J Pharm; 2014 Dec; 477(1-2):159-66. PubMed ID: 25455768
[TBL] [Abstract][Full Text] [Related]
13. Solid self-nanoemulsifying drug delivery systems for oral delivery of polypeptide-k: Formulation, optimization, in-vitro and in-vivo antidiabetic evaluation.
Garg V; Kaur P; Singh SK; Kumar B; Bawa P; Gulati M; Yadav AK
Eur J Pharm Sci; 2017 Nov; 109():297-315. PubMed ID: 28842349
[TBL] [Abstract][Full Text] [Related]
14. Preparation, Characterization and In Vivo Assessment of Repaglinide Nanosuspension for Oral Bioavailability Improvement.
Zawar LR; Bari SB
Recent Pat Drug Deliv Formul; 2018; 12(3):162-169. PubMed ID: 30003863
[TBL] [Abstract][Full Text] [Related]
15. Design and evaluation of self-nanoemulsifying pellets of repaglinide.
Desai NS; Nagarsenker MS
AAPS PharmSciTech; 2013 Sep; 14(3):994-1003. PubMed ID: 23775389
[TBL] [Abstract][Full Text] [Related]
16. Quetiapine Nanoemulsion for Intranasal Drug Delivery: Evaluation of Brain-Targeting Efficiency.
Boche M; Pokharkar V
AAPS PharmSciTech; 2017 Apr; 18(3):686-696. PubMed ID: 27207184
[TBL] [Abstract][Full Text] [Related]
17. Novel nanoemulsion for minimizing variations in bioavailability of ezetimibe.
Bali V; Ali M; Ali J
J Drug Target; 2010 Aug; 18(7):506-19. PubMed ID: 20067438
[TBL] [Abstract][Full Text] [Related]
18. Optimization of nutraceutical coenzyme Q10 nanoemulsion with improved skin permeability and anti-wrinkle efficiency.
El-Leithy ES; Makky AM; Khattab AM; Hussein DG
Drug Dev Ind Pharm; 2018 Feb; 44(2):316-328. PubMed ID: 29096550
[TBL] [Abstract][Full Text] [Related]
19. Vitamin E loaded resveratrol nanoemulsion for brain targeting for the treatment of Parkinson's disease by reducing oxidative stress.
Pangeni R; Sharma S; Mustafa G; Ali J; Baboota S
Nanotechnology; 2014 Dec; 25(48):485102. PubMed ID: 25392203
[TBL] [Abstract][Full Text] [Related]
20. Design and evaluation of oral nanoemulsion drug delivery system of mebudipine.
Khani S; Keyhanfar F; Amani A
Drug Deliv; 2016 Jul; 23(6):2035-43. PubMed ID: 26406153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
